Teladoc Health's Q4 2020 results showed significant growth, with revenue increasing by 145% year-over-year to $383.3 million and total visits up by 139% to 3.0 million. The company transformed to define a new category of whole-person virtual care. However, the company reported a net loss of $(394.0) million for the quarter, which included acquisition and integration-related costs and accelerated stock-based awards expense related to the merger with Livongo.
Q4 revenue increased 145% year-over-year to $383.3 million.
Total visits increased 139% to 3.0 million.
Net loss was $(394.0) million, including acquisition and integration costs and accelerated stock-based awards expense.
Full-year revenue grew 98% year-over-year to $1,094.0 million, and total visits increased 156% to 10.6 million.
Teladoc Health provided revenue guidance for Q1 2021 to be in the range of $445 million to $455 million and for FY 2021 to be in the range of $1.95 billion to $2.0 billion.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance